Hibernia Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-781
Closed -$228K 92
2026
Q1
$228K Buy
781
+24
+3% +$7.89K 0.07% 109
2025
Q4
$265K Buy
+757
New +$256K 0.08% 87
2025
Q3
Sell
-526
Closed -$204K 64
2025
Q2
$204K Buy
+526
New +$212K 0.07% 100
2024
Q3
Sell
-391
Closed -$211K 126
2024
Q2
$211K Buy
+391
New +$207K 0.07% 83
2023
Q4
Sell
-24
Closed -$10.5K 146
2023
Q3
$10.5K Buy
+24
New +$10.9K 0.01% 169

Other funds holding ELV

Hibernia Wealth Partners's ELV Position: Q2 2026 in Review

Hibernia Wealth Partners sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 781 shares — an estimated $228K sold.

Hibernia Wealth Partners first reported a position in ELV in Q3 2023 and held it in 5 quarters. The position peaked at $265K in Q4 2025. 466 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Hibernia Wealth Partners reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Hibernia Wealth Partners sold 781 Elevance Health shares in Q2 2026, an estimated $228K.
  • Hibernia Wealth Partners first reported a position in Elevance Health in Q3 2023 and held it in 5 quarters.
  • Hibernia Wealth Partners's Elevance Health position peaked at $265K in Q4 2025.
  • 466 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Hibernia Wealth Partners's 13F filing for Q2 2026, filed 23 Jul 2026.